Entire-body PET Scans for Multiple Sclerosis
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Entire-body PET Scans for Multiple Sclerosis is a clinical trial[1].
Key Facts
- Entire-body PET Scans for Multiple Sclerosis is in the country of United States[2].
- Entire-body PET Scans for Multiple Sclerosis's instance of is recorded as clinical trial[3].
- Entire-body PET Scans for Multiple Sclerosis's start time is recorded as +2021-03-01T00:00:00Z[4].
- Entire-body PET Scans for Multiple Sclerosis's end time is recorded as +2021-12-01T00:00:00Z[5].
- Entire-body PET Scans for Multiple Sclerosis's main subject is recorded as multiple sclerosis[6].
- Entire-body PET Scans for Multiple Sclerosis's main subject is recorded as sclerosis[7].
- Entire-body PET Scans for Multiple Sclerosis's number of participants is recorded as {'unit': '1', 'amount': '+20'}[8].
- Entire-body PET Scans for Multiple Sclerosis's title is recorded as Exploratory Study of Entire-body PET Scans for Multiple Sclerosis[9].
- Entire-body PET Scans for Multiple Sclerosis's short name is recorded as EPSMS[10].
- Entire-body PET Scans for Multiple Sclerosis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+25'}[11].
- Entire-body PET Scans for Multiple Sclerosis's ClinicalTrials.gov ID is recorded as NCT04390009[12].
- Entire-body PET Scans for Multiple Sclerosis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}[13].
- Entire-body PET Scans for Multiple Sclerosis's research intervention is recorded as radiopharmaceutical[14].
- Entire-body PET Scans for Multiple Sclerosis's clinical trial phase is recorded as phase I clinical trial[15].
- Entire-body PET Scans for Multiple Sclerosis's research subject recruitment status is recorded as not yet recruiting[16].
- Entire-body PET Scans for Multiple Sclerosis's study type is recorded as interventional study[17].